ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7
Work
Year: 2019
Type: article
Abstract: ISL1, a LIM-homeodomain transcription factor, serves as a biomarker of metastasis in multiple tumors. However, the function and underlying mechanisms of ISL1 in gastric cancer (GC) have not been full... more
Source: Cell Death and Disease
Cites: 54
Cited by: 42
Related to: 10
FWCI: 2.628
Citation percentile (by year/subfield): 79.75
Subfield: Molecular Biology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $3,422